Bimekizumab shows better Skin clearance in psoriasis compared to adalimumab in Phase 3 Data Hina Zahid4 Nov 2020 3:15 PM ISTBRUSSELS - UCB, a global biopharmaceutical company, today announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated...
Psoriasis successfully treated with topical Cannabinoids: Case report Dr Satabdi Saha16 Sept 2020 5:30 PM ISTAdam J. Friedman and his team, attached to the Department of Dermatology, The George Washington Medical Faculty Associates, Washington, DC, have...
Biologic therapy for psoriasis tied to significant plaque reduction in CAD Dr. Kamal Kant Kohli15 Sept 2020 3:15 PM ISTDallas- Researchers have found in a new study that Biologic therapy for psoriasis was associated with a significant reduction in high-risk plaque in...
Strides Pharma anti-inflammatory drug Prednisone gets USFDA nod Ruchika Sharma4 Sept 2020 11:15 AM ISTIt is used in the treatment of different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or...
Tapinarof shows promise in Plaque Psoriasis treatment in phase 3 trial results Dr Satabdi Saha30 Aug 2020 6:45 PM ISTResearchers have reported positive results with the use of Tapinarof cream (Dermavant Sciences), from 2 identical phase 3 studies.Both studies were...
Cadila Pharma launches arthritis biosimilar drug Cadalimab in India Ruchika Sharma29 Aug 2020 2:09 PM ISTCadalimab has shown to have significant reduction in signs and symptoms of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing...
Apremilast safe for psoriasis in elderly patients: study claims Dr Satabdi Saha10 Aug 2020 5:45 PM ISTAccording to a retrospective, real-world study, Apremilast, a drug recently developed for psoriasis have proved to be effective and safe in elderly...
Study finds Bimekizumab Superior to secukinumab for complete Psoriasis Skin Clearance Dr. Kamal Kant Kohli27 July 2020 6:15 PM ISTBRUSSELS- UCB, a global biopharmaceutical company, today announced positive results from the Phase 3b BE RADIANT study, a direct comparison of the...
COVID Cure: DCGI approves Itolizumab for restricted emergency use Ruchika Sharma11 July 2020 2:43 PM ISTIt is for the treatment of ‘cytokine’ release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19, they said.
Lupin, Mylan get European nod to market Nepexto for treating arthritis, psoriasis Ruchika Sharma5 Jun 2020 12:08 PM ISTMumbai: Lupin Limited and Mylan N.V. have announced that the European Commission (EC) has granted marketing authorization for Nepexto®, a biosimilar...
SPARC, Sun Pharma enter into license agreement for SCD-044, a potential treatment for atopic dermatitis, psoriasis, more Ruchika Sharma29 May 2020 4:25 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. and Sun Pharmaceutical Industries Ltd. have announced a worldwide licensing agreement on the...
AYUSH Minister inaugurates first advanced Homoeopathy Virology lab savita15 Sept 2017 9:30 AM ISTKolkata:Â The country's only laboratory to conduct basic research in Homoeopathy for viral diseases was inaugurated by Union Minister of State for...
